CK-MB Rapid Test (Immunofluorescence)

CK-MB Rapid Test (Immunofluorescence)

Quantitative CK-MB test for diagnosing heart injury. Results in 10 minutes using serum, plasma, or whole blood.

Description

CK-MB Rapid Test (Immunofluorescence)

The CK-MB Fast Test Kit is designed for the quantitative detection of Creatine Kinase MB (CK-MB) in human serum, plasma, or whole blood using immunofluorescence technology. This test is an important tool in the early diagnosis, risk assessment, and prognosis of myocardial injuries such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis, and Acute Coronary Syndrome (ACS).

About CK-MB

CK-MB is one of three creatine kinase isoenzymes, primarily found in cardiac muscle. Elevated CK-MB levels indicate myocardial damage and typically rise within 4–6 hours after cardiac injury, peaking at 10–24 hours, and returning to normal within 3–4 days.

Key Features

  • Quantitative detection range: 2.5–80.0 ng/mL
  • Cut-off: 5.0 ng/mL
  • Result in 10 minutes
  • Applicable to serum, plasma, and whole blood
  • Room temperature storage: 4–30°C

Specifications

Test Item Sample Type Method Detection Range Cut-off Test Time Storage Shelf Life
CK-MB Serum / Plasma / Whole Blood Immunofluorescence 2.5–80.0 ng/mL 5.0 ng/mL 10 min 4–30°C 24 months

Applicable Devices

  • Getein1100 / 1160 / 1180 / 1200 / 1600 Immunofluorescence Analyzers

Clinical Applications

  • Early diagnosis and monitoring of acute myocardial infarction (AMI)
  • Assessment of unstable angina and myocarditis
  • Evaluation of cardiac injury severity